A recent study has found that just more than 30 percent of people with cancer in Germany also experienced some form of clinically relevant mental health disorder. The article, published earlier this month in the Journal of Clinical Oncology, found that 32 percent of people with cancer, or about one in three, had also experienced a clinically meaningful level of … Read More
The Pharmacist’s Corner: What roles can pharmacists play in pharmacogenetics?
By Rachel Sass, PharmD What is your perception of a pharmacist? Someone in a white coat at the local pharmacy who fills your prescriptions, answers your questions and helps you pick out the right over-the-counter medicine? This is how pharmacists have historically been remembered, and while this area of pharmacy is still critical to the field, the pharmacist’s role has … Read More
Genelex named to top 100 fastest-growing businesses list for 2014
For the third time since Genelex was founded, the Seattle-based company leading the way in DNA sensitivity testing to help combat adverse drug events has been named one of Washington’s 100 fastest-growing private companies. The Puget Sound Business Journal has released its list of the state’s fastest-growing companies, and Genelex is included for the second year in a row. The … Read More
Celebrate pharmacists during the month of October
From maintaining a near-encyclopedic knowledge of potentially harmful drug interactions to easing the worries of first-time medication takers, pharmacists play a vital role in modern medical care. In honor of the many contributions pharmacists make to communities nationwide, the American Pharmacists Association has dubbed October American Pharmacists Month. The goal of American Pharmacists Month is to recognize the commitment that … Read More
DEA reschedules hydrocodone medications
The federal government has placed new restrictions on the prescribing of medications containing the opioid hydrocodone. Effective Oct. 6, the U.S. Drug Enforcement Agency (DEA) has published a final rule reclassifying hydrocodone combination products (HCPs), defined as medications combining hydrocodone and another drug, from Schedule III to the more restrictive Schedule II. The proposed rule follows the recommendation of a … Read More